×
Yubo Biotech Goodwill and Intangible Assets 2010-2024 | YBGJ
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Yubo Biotech goodwill and intangible assets from 2010 to 2024. Goodwill and intangible assets can be defined as the sum of all intangible asset fields
View More
Yubo Biotech Goodwill and Intangible Assets 2010-2024 | YBGJ
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Yubo Biotech goodwill and intangible assets from 2010 to 2024. Goodwill and intangible assets can be defined as the sum of all intangible asset fields
Related Stocks
Company Name
Market
Cap
Thermo Fisher Scientific (TMO)
$206.8B
Intuitive Surgical (ISRG)
$191.3B
Alcon (ALC)
$42.9B
Edwards Lifesciences (EW)
$38.8B
IQVIA Holdings (IQV)
$38.8B
IDEXX Laboratories (IDXX)
$34.9B
DexCom (DXCM)
$29B
Waters (WAT)
$22.9B
STERIS (STE)
$22B
SONOVA HOLDING (SONVY)
$21.6B
Hologic (HOLX)
$18.5B
Sysmex ADR (SSMXY)
$12.6B
Fresenius Medical Care AG KGaA (FMS)
$12.4B
Globus Medical (GMED)
$11.3B
Teleflex (TFX)
$9.1B
Penumbra (PEN)
$9.1B
Masimo (MASI)
$8.6B
Glaukos (GKOS)
$7.9B
PROCEPT BioRobotics (PRCT)
$5B
Integer Holdings (ITGR)
$4.6B
TransMedics (TMDX)
$3.1B
Inari Medical (NARI)
$3B
Veracyte (VCYT)
$3B
LivaNova (LIVN)
$2.9B
Nihon Kohden (NHNKY)
$2.6B
Elekta AB (EKTAY)
$2.3B
Tandem Diabetes Care (TNDM)
$2B
Integra LifeSciences Holdings (IART)
$1.9B
RxSight (RXST)
$1.8B
Alphatec Holdings (ATEC)
$1.3B